<DOC>
	<DOCNO>NCT02079766</DOCNO>
	<brief_summary>This study explore use 18F-AV-1451 biomarker chronic traumatic encephalopathy ( CTE ) examine relationship clinical presentation tau deposition .</brief_summary>
	<brief_title>18F-AV-1451 Florbetapir F 18 PET Imaging Subjects Risk Chronic Traumatic Encephalopathy</brief_title>
	<detailed_description />
	<mesh_term>Brain Diseases</mesh_term>
	<mesh_term>Brain Injuries</mesh_term>
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Brain Injury , Chronic</mesh_term>
	<criteria>Male subject consent currently enrol Diagnosing Evaluating Traumatic Encephalopathy Using Clinical Tests ( DETECT ) LongTerm Consequences Repetitive Brain Injury Athletes study protocol Can tolerate two PET image session Have ability provide inform consent study procedure Claustrophobia Current clinically significant cardiovascular disease clinically significant abnormality screen ECG History risk factor Torsades de Pointes take drug know cause QTprolongation Current clinically significant infectious disease , endocrine metabolic disease , pulmonary , renal hepatic impairment , cancer investigator believe would affect study participation scan result Have nonstudy related radiopharmaceutical imaging treatment within 7 day prior study PET imaging session</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>